Chinese ownership could unlock synergies but pricing pressure causing challenges, warns Tasmanian Botanics boss by Adam Sheldon April 8, 2026April 8, 2026 As Tasmanian Botanics prepares to come under almost full control of Chinese investors, the cultivator’s CEO […]
Former Althea CEO Josh Fegan accuses firm of breach of contract by Steve Jones April 7, 2026April 7, 2026
News in brief: Puro completes first hash export; GrowerIQ renews GMP compliance; MedReleaf inks Leafio deal; Vitura forms advisory group; Althea to become Peak Processing by Adam Sheldon December 2, 2025February 21, 2026
Althea creditors to recover four cents in the dollar under DOCA by Adam Sheldon August 20, 2025August 20, 2025
Josh Fegan quits Althea Group, leaving ‘purpose and a bright future’ by Adam Sheldon July 24, 2025July 24, 2025
Tasmanian Botanics releases first Althea product as CEO flags unique opportunity to rebuild brand by Adam Sheldon July 16, 2025July 16, 2025
Althea says A$2m placement exempt from ASX ruling on equity securities by Martin Lane January 7, 2025January 7, 2025
Althea bosses agree to pay cut as group records first cash flow positive quarter by Martin Lane October 11, 2023October 12, 2023
